MedMira Inc.
MIR.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -47.93% | 78.41% | -23.24% | -12.96% | -4.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.93% | 78.41% | -23.24% | -12.96% | -4.30% |
| Cost of Revenue | -4.50% | 55.27% | 8.10% | 5.52% | 10.81% |
| Gross Profit | -33.30% | -49.15% | -40.21% | -38.76% | -28.65% |
| SG&A Expenses | 24.63% | 130.96% | -39.04% | 79.63% | 72.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.61% | 87.98% | -7.47% | 21.93% | 13.40% |
| Operating Income | -76.02% | -88.74% | 4.82% | -38.01% | -17.72% |
| Income Before Tax | -65.77% | -18.90% | -31.98% | -20.25% | -20.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.77% | -18.90% | -31.98% | -20.25% | -20.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.77% | -18.90% | -31.98% | -20.25% | -20.92% |
| EBIT | -76.02% | -88.74% | 4.82% | -38.01% | -17.72% |
| EBITDA | -79.60% | -89.50% | 5.57% | -43.44% | -19.39% |
| EPS Basic | -75.00% | -20.00% | -33.33% | -20.00% | -14.29% |
| Normalized Basic EPS | -60.00% | -33.33% | -25.00% | -33.33% | -25.00% |
| EPS Diluted | -87.50% | 0.00% | -14.29% | 0.00% | 0.00% |
| Normalized Diluted EPS | -60.00% | -33.33% | -25.00% | -33.33% | -25.00% |
| Average Basic Shares Outstanding | 0.61% | 0.61% | 0.61% | 0.09% | 0.00% |
| Average Diluted Shares Outstanding | 0.61% | 0.61% | 0.61% | 0.09% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
